LDS/Medical Tests/Actin (Smooth Muscle) Antibody, IgG

Actin (Smooth Muscle) Antibody, IgG

Actin, a globular protein ubiquitous in eukaryotic cells, polymerizes into filamentous actin (F-actin), forming a critical component of the cytoskeleton. F-actin is involved in fundamental cellular processes including maintaining cell shape, motility, division, and intracellular trafficking. Smooth muscle actin, a specific actin isoform found exclusively in smooth muscle cells, is essential for muscle contraction through interaction with myosin.

Autoimmune diseases such as autoimmune hepatitis (AIH), autoimmune cholangitis, and primary biliary cholangitis (PBC) are associated with autoantibodies targeting smooth muscle actin. Elevated serum levels of actin (smooth muscle) IgG antibodies are commonly detected in AIH patients (52–85% prevalence). Additionally, these antibodies are found in approximately 65% of autoimmune cholangitis and 30% of PBC cases. Nonetheless, up to 2% of healthy individuals may exhibit positivity without clinical implications.

AIH frequently remains asymptomatic in early stages, with abnormal liver function tests typically leading to diagnosis. Advanced AIH presents clinical manifestations such as jaundice, ascites, and hepatic failure. AIH type I, the most prevalent form, often features concurrent autoantibodies including antinuclear antibody (ANA) and perinuclear anti-neutrophil cytoplasmic antibody (P-ANCA).

  • Diagnostic aid for autoimmune hepatitis, autoimmune cholangitis, and primary biliary cholangitis
  • Monitoring therapeutic response and disease progression in patients with autoimmune liver diseases
  • Positive result (≥20 U): Suggestive of autoimmune liver disease, especially autoimmune hepatitis, autoimmune cholangitis, or primary biliary cholangitis.
  • Negative result (<20 U): Significantly reduces likelihood but does not exclude autoimmune liver disorders entirely. Decreased levels: Observed in immunodeficiency disorders such as Severe Combined Immunodeficiency (SCID).

Negative: <20 U Positive: > or = 20 U

Indirect Immunofluorescence (IFA).

Serum (SST tube).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 21 days
ALT, AST, ALP, Total bilirubin, IgG, mitochondrial antibody IgG, liver biopsy, AFP, Hepatitis virus screening, liver cytosolic antigen type 1, P-ANCA, C-ANCA, ANA, HLA-DRB3/4/5.
2-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login